LIU Si-yang, TU Hai-yan, WU Yi-long. With The Largest Sample Size, To Explore The Prognosis and Treatment among Uncommon EGFR Mutations with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 321-321. DOI: 10.12019/j.issn.1671-5144.2017.06.001
|
Citation:
|
LIU Si-yang, TU Hai-yan, WU Yi-long. With The Largest Sample Size, To Explore The Prognosis and Treatment among Uncommon EGFR Mutations with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 321-321. DOI: 10.12019/j.issn.1671-5144.2017.06.001
|
LIU Si-yang, TU Hai-yan, WU Yi-long. With The Largest Sample Size, To Explore The Prognosis and Treatment among Uncommon EGFR Mutations with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 321-321. DOI: 10.12019/j.issn.1671-5144.2017.06.001
|
Citation:
|
LIU Si-yang, TU Hai-yan, WU Yi-long. With The Largest Sample Size, To Explore The Prognosis and Treatment among Uncommon EGFR Mutations with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2017, 17(6): 321-321. DOI: 10.12019/j.issn.1671-5144.2017.06.001
|
DownLoad: